Nuevas formas de vehiculización de agentes hipotensores para el tratamiento del glaucoma

  1. Andres Guerrero, Vanessa
unter der Leitung von:
  1. María del Rocío Herrero Vanrell Doktormutter
  2. Irene Teresa Molina Martínez Doktormutter

Universität der Verteidigung: Universidad Complutense de Madrid

Fecha de defensa: 29 von Juni von 2011

Gericht:
  1. Julián García Feijoo Präsident
  2. Beatriz de las Heras Polo Sekretärin
  3. Virginia Merino Sanjuán Vocal
  4. Nicolas Tsapis Vocal
  5. Carmen Álvarez Lorenzo Vocal
Fachbereiche:
  1. Farmacia Galénica y Tecnología Alimentaria

Art: Dissertation

Teseo: 113230 DIALNET

Zusammenfassung

Glaucoma is the second leading cause of blin dness in the world. It is a chronic optic neuropathy which can lead to complete loss of vision if an adequate treatment is not used in time. At the moment there is no cure for glaucoma and the available treatments are chronic and only manage to contr ol or decrease the evolution of the pathology. These types of treatments, consisting of the instillation of eye drops once or twice per day, are usually associated to short- and long-term adverse effects that compromise the patient compliance...